Palleon Pharmaceuticals Recognized as a Fierce Biotech “Fierce 15” Company for 2023

Palleon named as one of Fierce Biotech

Ruojing (Angus) Liu sur LinkedIn : J&J's pharma group quietly works through global overhaul, with layoffs…

Palleon Pharmaceuticals on LinkedIn: #fierce15

Alan Colowick on LinkedIn: Novo Nordisk and Life Edit Therapeutics Establish Multi-Target…

Palleon Pharmaceuticals on LinkedIn: See you in Taipei, Taiwan in 2023.

Introducing Fierce Biotech's 2023 Fierce 15

Apnimed LinkedIn

Chris Jenkins on LinkedIn: Introducing Fierce Biotech's 2023 Fierce 15

Alan Colowick on LinkedIn: Congratulations on this recognition to the entire team at ReCode…

Alan Colowick on LinkedIn: Public Exchange Health and Wellbeing Practice Director

Palleon Pharmaceuticals

E-602: Drug Targets, Indications, Patents - Synapse

Vantage September 2023 - Vertex Ventures Holdings